semaglutide vs tirzepatide for inflammation GLP-1 Medications Weight Loss: vs Retat – Revolution Health & Wellness Tirzepatide and semaglutide, the ingredients

Methods A pooled post hoc analysis of 11 randomized clinical trials (N = 4595) of 1030 weeks duration from the exenatide once-weekly (QW) development program evaluated heart rate with exenatide QW (intervention group) and exenatide twice daily (BID), liraglutide, and non-GLP-1RAs (insulin, metformin, pioglitazone, and sitagliptin) (comparison groups)

Whole Body Overall metabolic improvements: Insulin sensitivity cells use insulin more effectively Muscle fat infiltration less fat stored in muscle Subcutaneous, abdominal, and visceral fat reduces unhealthy fat deposits

Semaglutide Targets GLP-1 receptors to help reduce appetite and slow digestion

Tirzepatide typically delivers greater weight loss than semaglutide by targeting GLP-1 and GIP receptors, while both reduce appetite and improve blood sugar.

Retaklik is typically administered through a subcutaneous injection, which means the medication is injected under the skin

Discover how to support your patients weight loss journeys with treatments that tackle skin laxity, increase satisfaction, and drive practice profitability